Navid Hafez
Director of Precision Medicine and Thoracic Oncology · The Angeles Clinic and Research Institute
Credentials: · · · · · · ·
History
2023–Present
- 2015–2017
Medical Oncology
- 2012–2015
Internal Medicine
- 2011–2012
Research
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet · 2020 · 1,345 citations
Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation
Journal of Clinical Oncology · 2023 · 271 citations
Journal of the American Academy of Dermatology · 2018 · 159 citations
- JE
6 papers
5 papers
- JS
4 papers
3 papers · 2 as a fellow
3 papers
3 papers
3 papers
- AS
2 papers
Clinical trials
- 2026–2028
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Site PI · Recruiting · Phase 2
Verastem, Inc.
- 2026–2028
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 2
Verastem, Inc.
- 2026–2028
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
InduPro, Inc.
- 2026–2029
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Site PI · Recruiting · Phase 1
Flare Therapeutics Inc.